Gastroparesis [clinicaltrials_resource:c876b0cbfc7324eea053aef4b14af6db]
Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying [clinicaltrials:NCT00050609]Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis [clinicaltrials:NCT00050882]A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time [clinicaltrials:NCT00128284]clinicaltrials:NCT00157755Effect of Electroacupuncture in Diabetic Patients With Gastroparesis [clinicaltrials:NCT00227383]Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia [clinicaltrials:NCT00370084]clinicaltrials:NCT00372970Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis [clinicaltrials:NCT00390975]Gastroparesis Registry [clinicaltrials:NCT00398801]clinicaltrials:NCT00432835Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis [clinicaltrials:NCT00492622]clinicaltrials:NCT00501657clinicaltrials:NCT00552422Enterra Therapy Gastric Stimulation System [clinicaltrials:NCT00556166]A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040 [clinicaltrials:NCT00562848]Gastric Pacemaker Implantation for Gastroparesis [clinicaltrials:NCT00568373]Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis [clinicaltrials:NCT00612014]Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis [clinicaltrials:NCT00639808]A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time - Over 65 Years Old [clinicaltrials:NCT00682877]Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects. [clinicaltrials:NCT00733551]Domperidone in Refractory Gastroparesis [clinicaltrials:NCT00760461]Domperidone for Relief of Gastrointestinal Disorders [clinicaltrials:NCT00761254]Domperidone for Refractory Gastrointestinal Disorders [clinicaltrials:NCT00777439]clinicaltrials:NCT00845858The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis [clinicaltrials:NCT00861809]Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus [clinicaltrials:NCT00889486]Medico-economic Evaluation of ENTERRA Therapy [clinicaltrials:NCT00903799]Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance [clinicaltrials:NCT01039805]GSK962040 Drug-drug Interaction Study With Ketoconazole [clinicaltrials:NCT01039974]Temporary Gastric Electrical Stimulation for Gastroparesis [clinicaltrials:NCT01054794]Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers [clinicaltrials:NCT01074710]Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients [clinicaltrials:NCT01117376]The Purpose of This Pilot Study is to Assess the Impact of KUVAN® (Sapropterin Dihydrochloride) on Gastric Relaxation in Women With Diabetic Gastroparesis. [clinicaltrials:NCT01135186]clinicaltrials:NCT01149369Idiopathic Gastroparesis Registry Using a Predominant-Symptom Classification [clinicaltrials:NCT01173484]A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus) [clinicaltrials:NCT01206582]Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis [clinicaltrials:NCT01262898]A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers [clinicaltrials:NCT01267071]An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment Options [clinicaltrials:NCT01281540]An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus [clinicaltrials:NCT01286090]
condition [clinicaltrials_vocabulary:condition]
Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying [clinicaltrials:NCT00050609]Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis [clinicaltrials:NCT00050882]A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time [clinicaltrials:NCT00128284]A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis [clinicaltrials:NCT00139893]clinicaltrials:NCT00157755Effect of Electroacupuncture in Diabetic Patients With Gastroparesis [clinicaltrials:NCT00227383]Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia [clinicaltrials:NCT00370084]clinicaltrials:NCT00372970Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis [clinicaltrials:NCT00390975]Gastroparesis Registry [clinicaltrials:NCT00398801]clinicaltrials:NCT00432835Acupuncture for Diabetic Gastroparesis [clinicaltrials:NCT00470795]Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis [clinicaltrials:NCT00492622]clinicaltrials:NCT00501657clinicaltrials:NCT00552422Enterra Therapy Gastric Stimulation System [clinicaltrials:NCT00556166]A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040 [clinicaltrials:NCT00562848]Gastric Pacemaker Implantation for Gastroparesis [clinicaltrials:NCT00568373]Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis [clinicaltrials:NCT00595621]Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis [clinicaltrials:NCT00612014]Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy [clinicaltrials:NCT00622804]Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis [clinicaltrials:NCT00639808]A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time - Over 65 Years Old [clinicaltrials:NCT00682877]Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects. [clinicaltrials:NCT00733551]Domperidone in Refractory Gastroparesis [clinicaltrials:NCT00760461]Domperidone for Relief of Gastrointestinal Disorders [clinicaltrials:NCT00761254]clinicaltrials:NCT00765895The Effect of Oxytocin on the Gastric Emptying [clinicaltrials:NCT00776360]Domperidone for Refractory Gastrointestinal Disorders [clinicaltrials:NCT00777439]clinicaltrials:NCT00845858The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis [clinicaltrials:NCT00861809]The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis [clinicaltrials:NCT00874133]Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus [clinicaltrials:NCT00889486]Medico-economic Evaluation of ENTERRA Therapy [clinicaltrials:NCT00903799]Gastric vs Jejunal Feeding in Diabetic Gastroparesis [clinicaltrials:NCT00944593]clinicaltrials:NCT01030341Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance [clinicaltrials:NCT01039805]GSK962040 Drug-drug Interaction Study With Ketoconazole [clinicaltrials:NCT01039974]Temporary Gastric Electrical Stimulation for Gastroparesis [clinicaltrials:NCT01054794]Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers [clinicaltrials:NCT01074710]
condition browse [clinicaltrials_vocabulary:condition-browse]
Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying [clinicaltrials:NCT00050609]Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis [clinicaltrials:NCT00050882]A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time [clinicaltrials:NCT00128284]A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis [clinicaltrials:NCT00139893]clinicaltrials:NCT00157755Effect of Electroacupuncture in Diabetic Patients With Gastroparesis [clinicaltrials:NCT00227383]Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia [clinicaltrials:NCT00370084]clinicaltrials:NCT00372970Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis [clinicaltrials:NCT00390975]Gastroparesis Registry [clinicaltrials:NCT00398801]clinicaltrials:NCT00432835Acupuncture for Diabetic Gastroparesis [clinicaltrials:NCT00470795]Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis [clinicaltrials:NCT00492622]clinicaltrials:NCT00501657clinicaltrials:NCT00552422Enterra Therapy Gastric Stimulation System [clinicaltrials:NCT00556166]A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040 [clinicaltrials:NCT00562848]Gastric Pacemaker Implantation for Gastroparesis [clinicaltrials:NCT00568373]Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis [clinicaltrials:NCT00595621]Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis [clinicaltrials:NCT00612014]Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy [clinicaltrials:NCT00622804]Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis [clinicaltrials:NCT00639808]A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time - Over 65 Years Old [clinicaltrials:NCT00682877]Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects. [clinicaltrials:NCT00733551]Domperidone in Refractory Gastroparesis [clinicaltrials:NCT00760461]Domperidone for Relief of Gastrointestinal Disorders [clinicaltrials:NCT00761254]clinicaltrials:NCT00765895The Effect of Oxytocin on the Gastric Emptying [clinicaltrials:NCT00776360]Domperidone for Refractory Gastrointestinal Disorders [clinicaltrials:NCT00777439]clinicaltrials:NCT00845858The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis [clinicaltrials:NCT00861809]The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis [clinicaltrials:NCT00874133]Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus [clinicaltrials:NCT00889486]Medico-economic Evaluation of ENTERRA Therapy [clinicaltrials:NCT00903799]Gastric vs Jejunal Feeding in Diabetic Gastroparesis [clinicaltrials:NCT00944593]clinicaltrials:NCT01030341Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance [clinicaltrials:NCT01039805]GSK962040 Drug-drug Interaction Study With Ketoconazole [clinicaltrials:NCT01039974]Temporary Gastric Electrical Stimulation for Gastroparesis [clinicaltrials:NCT01054794]Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers [clinicaltrials:NCT01074710]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Gastroparesis [clinicaltrials_resource:c876b0cbfc7324eea053aef4b14af6db]
Bio2RDF identifier
c876b0cbfc7324eea053aef4b14af6db
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c876b0cbfc7324eea053aef4b14af6db
identifier
clinicaltrials_resource:c876b0cbfc7324eea053aef4b14af6db
title
Gastroparesis
@en
type
label
Gastroparesis [clinicaltrials_resource:c876b0cbfc7324eea053aef4b14af6db]
@en
Gastroparesis